Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo

Author:

Liu Xuejiao12,Song Mengqiu12,Wang Penglei12,Zhao Ran12,Chen Hanyong3,Zhang Man2,Shi Yuanyuan2,Liu Kangdong124,Liu Fangfang12,Yang Ran2,Li Enmin5,Bode Ann M.3,Dong Zigang1234,Lee Mee‐Hyun123ORCID

Affiliation:

1. School of Basic Medical SciencesZhengzhou University Zhengzhou Henan China

2. China‐US (Henan) Hormel Cancer Institute Zhengzhou Henan China

3. The Hormel Institute, University of Minnesota Austin Minnesota

4. The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention Zhengzhou Henan China

5. Department of Biochemistry and Molecular BiologyShantou University Medical College Shantou Guangdong China

Funder

National Institutes of Health

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference44 articles.

1. Identification of genomic alterations in oesophageal squamous cell cancer

2. Oesophageal cancer

3. Cancer incidence and mortality: A cohort study in China, 2008–2013

4. Cancer statistics in China, 2015

5. Effects of neoadjuvant 5‐fluorouracil and cisplatin therapy in patients with clinical stage II/III esophageal squamous cell carcinoma;Konishi H;Anticancer Res,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3